Balanitis Xerotica Obliterans (BXO) Clinical Trial
— BXOOfficial title:
Circumcision Versus Preputioplasty for BXO in Children: A Feasibility Randomised Controlled Trial
NCT number | NCT02854995 |
Other study ID # | BXO |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2016 |
Est. completion date | November 7, 2018 |
Verified date | October 2017 |
Source | Alder Hey Children's NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Traditionally, BXO is managed with circumcision (surgical removal of the foreskin) and this
approach has long been held as the 'gold standard. Whilst this may be curative in many cases,
it has been shown that 20% of boys require a further operative procedure on their penis to
widen the urethral opening (to treat meatal stenosis)
An alternative to circumcision was proposed: a preputioplasty (surgery to widen the opening
of the foreskin) was combined with injection of steroids into the affected foreskin.
Subsequently, the same group compared the outcomes of this technique with circumcision, and
reported circumcision was successfully avoided in 92% of the preputioplasty group. In
addition, the rate of meatal stenosis (narrowing of the urethral opening requiring surgery)
was significantly lower (6% vs 19%, P = .034 ). Preputioplasty may therefore: (i) offer
protection against meatal stenosis and reduce the requirement for further surgery; and (ii)
offer the benefit of retaining the foreskin, the function of which, while debated, likely
includes sexual function. In view of these potential benefits, authors have called for a
randomised trial to compare circumcision to preputioplasty and injection of steroids.
Status | Completed |
Enrollment | 20 |
Est. completion date | November 7, 2018 |
Est. primary completion date | January 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 16 Years |
Eligibility |
Inclusion Criteria: - aged between 2 and 16 years - diagnosed with BXO - require surgery to treat BXO Exclusion Criteria: - previous penile surgery - circumcision or preputioplasty medically contraindicated |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Alder Hey Children's Hospital | Liverpool | Merseyside |
Lead Sponsor | Collaborator |
---|---|
Alder Hey Children's NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment Rate | Recruitment Rate including reasons for non-recruitment. | 12 months | |
Primary | Protocol Adherence | Rate of adherence to protocol-data collected by study team | 12 months | |
Primary | Drop Out | Rate of drop-out from the study | 12 months | |
Secondary | Patient Satisfaction | Satisfaction with treatment process (at 6 weeks) and overall outcome (3 and 12 months) - data collected by questionnaire | 6 weeks, 3 months and 12 months | |
Secondary | Clinical outcomes-Readmissions to hospital | Readmissions to hospital (number of readmissions within 30 days) | 30 days | |
Secondary | Clinical outcomes-Surgical complications | Surgical complications: specifically, wound infection (defined by intention to treat with antibiotics); urinary retention requiring intervention; post-operative bleeding requiring return to theatre | 72 hours | |
Secondary | Clinical outcomes-Return to theatre | Return to theatre for a complication (within 30 days) | 30 days | |
Secondary | Clinical outcomes-patient satisfaction | Medium term patient satisfaction (questionnaire at 3 months and 1 year) | 3 months & 1 year | |
Secondary | Clinical outcomes-functional outcomes | Functional outcomes: urinary flow rate at 6 weeks, 3 months and 1 year | 6 weeks, 3 months & 1 year | |
Secondary | Clinical outcomes-Subsequent penile surgery | Subsequent penile surgery (other than for early complication): e.g. meatal procedure, re-do preputioplasty or circumcision | 1 year |